CDKN2B and leukemia: Because p15INK4B is barely detectable in leukemia cells, to test our hypothesis, we mainly focused on the aspect of p15INK4B upregulation and NCL inactivation using siRNA or AS1411 in Kasumi-1 or MV4-11 cells.